These results demonstrated that the duration of anti-Spike RBD antibodies was longer in the sera of convalescent COVID-19 patients than in sera of vaccinated subjects who had received two doses of inactivated SARS-CoV-2 vaccine. Here, CHMP5 is linked to COVID-19.